Investors Research Corp Novartis Ag Transaction History

Investors Research Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$80.03 - $92.81 $16,006 - $18,562	-200 Reduced 6.34%	2,953 $271,000
Q1 2021 Apr 28, 2021	SELL	$83.5 - $98.47 $41,750 - $49,235	-500 Reduced 13.69%	3,153 $270,000
Q2 2018 Aug 10, 2018	BUY	$64.91 - $73.36 $1,882 - $2,127	29 Added 0.8%	3,653 $276,000
Q4 2017 Feb 13, 2018	BUY	$72.33 - $77.64 $262,123 - $281,367	3,624	3,624 $304,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Investors Research Corp, based on Form 13F filings with the SEC.

Stay updated on Investors Research Corp with notifications on news.